Michael Barbella, Managing Editor11.07.23
Minimal access surgeries (MAS) have gained popularity due to reduced post-operative pain, shorter hospital stays, and quicker recoveries. In India, where a large population seeks affordable healthcare, the success of MAS relies heavily on efficient suturing techniques that are vital to minimize complications and infections.
Consequently, the domestic surgical sutures market will grow more than 13% annually to reach $380 million in 2030, forecasts GlobalData.
The company’s report, “India Surgical Sutures Market Share,” reveals that India will account for about 18% of the Asia-Pacific (APAC) surgical sutures market this year (by revenue).
“Traditional suturing techniques in India often involve using metal clips, plasters, and bandages. However, such techniques are known to pose risks due to poor sterilization and cause unwanted reactions in patients,” GlobalData Medical Devices Analyst Ayshi Ganguly said. “Furthermore, the limited number of skilled practitioners and poor access to healthcare in rural areas have been additional drawbacks. This drives the requirement of alternative suturing techniques that can reduce the complications associated with traditional sutures.”
Against this backdrop, surgical sutures have efficiently sealed wounds and incisions by securely holding the tissue together, reducing the risk of infection and minimizing scarring, making them an effective tool in MAS. Ethicon Inc., Arthrex Inc., and Covidien Holding Inc. are some of the market’s key players.
Healthium Medtech Ltd. recently introduced its first exclusive range of surgical sutures, TRUMAS, in India. The company claims the sutures offer an anti-reflective coating to reduce eye fatigue for surgeons and the curved and squared body offers better insertion and grip. Suture length flexibility reportedly allows surgeons to perform critical surgeries with ease.
“Following the steps taken by Healthium, other domestic companies are expected to establish a significant presence in the Indian surgical sutures market, where MAS are burgeoning. In addition, India’s ‘Make-in-India’ policy aims to boost domestic manufacturing of such medical equipment and devices, thereby reducing dependence on imports in the upcoming years,” Ganguly noted. “The development of such devices will expand the scope of exports and create a favorable business environment for the healthcare sector. With this, the Indian surgical sutures market is all set to flourish, offering promising domestic and export opportunities for Indian manufacturers.”
Consequently, the domestic surgical sutures market will grow more than 13% annually to reach $380 million in 2030, forecasts GlobalData.
The company’s report, “India Surgical Sutures Market Share,” reveals that India will account for about 18% of the Asia-Pacific (APAC) surgical sutures market this year (by revenue).
“Traditional suturing techniques in India often involve using metal clips, plasters, and bandages. However, such techniques are known to pose risks due to poor sterilization and cause unwanted reactions in patients,” GlobalData Medical Devices Analyst Ayshi Ganguly said. “Furthermore, the limited number of skilled practitioners and poor access to healthcare in rural areas have been additional drawbacks. This drives the requirement of alternative suturing techniques that can reduce the complications associated with traditional sutures.”
Against this backdrop, surgical sutures have efficiently sealed wounds and incisions by securely holding the tissue together, reducing the risk of infection and minimizing scarring, making them an effective tool in MAS. Ethicon Inc., Arthrex Inc., and Covidien Holding Inc. are some of the market’s key players.
Healthium Medtech Ltd. recently introduced its first exclusive range of surgical sutures, TRUMAS, in India. The company claims the sutures offer an anti-reflective coating to reduce eye fatigue for surgeons and the curved and squared body offers better insertion and grip. Suture length flexibility reportedly allows surgeons to perform critical surgeries with ease.
“Following the steps taken by Healthium, other domestic companies are expected to establish a significant presence in the Indian surgical sutures market, where MAS are burgeoning. In addition, India’s ‘Make-in-India’ policy aims to boost domestic manufacturing of such medical equipment and devices, thereby reducing dependence on imports in the upcoming years,” Ganguly noted. “The development of such devices will expand the scope of exports and create a favorable business environment for the healthcare sector. With this, the Indian surgical sutures market is all set to flourish, offering promising domestic and export opportunities for Indian manufacturers.”